The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
FDA’s Clinical Methodologies Group (ClinMeth) received a $9.2 million grant through the HHS Office of the Assistant Secretary for Planning and ...
read more
Arecor Limited, a biopharmaceutical company, announced that it has signed a formulation study partnership with Eli Lilly and Company (“Lilly”), an ...
read more
The FDA published a new batch of product-specific guidelines (PSGs). PSGs provide recommendations for developing generic drugs and generating the ...
read more
Maxwell Biosciences, a biotechnology company, announced patented biostable peptide analogs that function as mimics of the cathelicidin peptide - the ...
read more
APEIRON Biologics, a private European biotech company, announced next steps for APN01 (alunacedase alfa) for COVID-19 treatment.
Based on the results...
read more
Actinium announced that initial patient enrollment in the second dose cohort in the Phase 1 portion of the Actimab-A venetoclax trial in fit and unfit...
read more
Astellas and Seagen announced a MAA for enfortumab vedotin was accepted by the EMA.
read more
Milestone announced the first patient has been enrolled in its Phase 2 proof-of-concept study of etripamil nasal spray for the Reduction of ...
read more
Wednesday, March 31, 2021
Actinium announced its collaborator, MSK, has commenced patient enrollment in the Phase 1 study evaluating Iomab-ACT for targeted conditioning prior ...
read more
Wednesday, March 31, 2021
Clover and Dynavax announced the first participants have been dosed in Clover's SPECTRA trial, a global Phase 2/3 clinical trial evaluating the ...
read more
Wednesday, March 31, 2021
Exacis Biotherapeutics announced several steps in the preclinical development of its ExaNK™ engineered NK cell-therapy candidates.
read more
NeuroRx reports 60-day results of the Phase 2b/3 trial of intravenously-administered ZYESAMI for the treatment of respiratory failure in critically-...
read more
AstraZeneca Pharmaceuticals
Positive high-level results from the primary analysis of the Phase III trial of AZD1222 in the US have confirmed vaccine efficacy consistent with the ...
read more
The FDA approved pembrolizumab in combination with platinum and fluoropyrimidine-based chemotherapy for metastatic or locally advanced esophageal or ...
read more
Wednesday, March 24, 2021
The FDA authorized revised fact sheets for health care providers to include additional information on susceptibility of SARS-CoV-2 variants to each of...
read more